Literature DB >> 8882514

Non-viral gene transfer: applications in developmental biology and gene therapy.

B Abdallah1, L Sachs, B A Demeneix.   

Abstract

The main limitation of non-viral gene transfer methods is their relatively low efficiency in vivo. However, a number of approaches can be taken to improve their performances, whether the aim is studying gene function during development or employing these techniques for gene therapy. Three non-viral delivery systems that we have been particularly involved in in developing are described: the cationic lipid, dioctadecylamidoglycylspermine (DOGS), the cationic polymer polyethylenimine (PEI) and free DNA. The application of each of these methods to different in vivo situations is presented: the use of DOGS for transfecting embryos and the developing mammalian nervous system; the recent application of PEI to the nervous system; and how naked DNA can be employed for transfecting different muscles and brain. The relative efficiencies are compared on the basis of luciferase reporter gene expression assessed in each tissue with the most appropriate vector system. Finally, the perspectives for constructing composite vectors combining safety and efficiency are considered briefly.

Entities:  

Mesh:

Year:  1995        PMID: 8882514

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  8 in total

1.  Engineering viral promoters for gene transfer to human neuroblasts.

Authors:  A Cara; E Lucarelli; P Cornaglia-Ferraris
Journal:  Cell Mol Neurobiol       Date:  2000-06       Impact factor: 5.046

2.  In vitro transfection of plasmid DNA by amine derivatives of gelatin accompanied with ultrasound irradiation.

Authors:  Hossein Hosseinkhani; Ternyoshi Aoyama; Shingo Yamamoto; Osamu Ogawa; Yasuhiko Tabata
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

3.  Re-examination of Peptide-Sequence-Dependent Gene Expression of Cysteine-Installed Pegylated Oligolysine/DNA Complexes.

Authors:  Yuichi Yamasaki; Daiki Kumekawa; Satoshi Yamauchi; Hodaka Omuro
Journal:  ACS Omega       Date:  2022-04-27

4.  Size-uniform 200 nm particles: fabrication and application to magnetofection.

Authors:  Lamar Mair; Kris Ford; M d Rowshon Alam; Ryszard Kole; Michael Fisher; Richard Superfine
Journal:  J Biomed Nanotechnol       Date:  2009-04       Impact factor: 4.099

5.  The role of ganglioside GM1 in cellular internalization mechanisms of poly(amidoamine) dendrimers.

Authors:  Seungpyo Hong; Rahul Rattan; István J Majoros; Douglas G Mullen; Jennifer L Peters; Xiangyang Shi; Anna U Bielinska; Luz Blanco; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Bioconjug Chem       Date:  2009-07-07       Impact factor: 4.774

6.  Ex vivo nonviral gene delivery of μ-opioid receptor to attenuate cancer-induced pain.

Authors:  Seiichi Yamano; Chi T Viet; Dongmin Dang; Jisen Dai; Shigeru Hanatani; Tadahiro Takayama; Hironori Kasai; Kentaro Imamura; Ron Campbell; Yi Ye; John C Dolan; William Myung Kwon; Stefan D Schneider; Brian L Schmidt
Journal:  Pain       Date:  2017-02       Impact factor: 7.926

7.  Development of 3D in vitro platform technology to engineer mesenchymal stem cells.

Authors:  Hossein Hosseinkhani; Po-Da Hong; Dah-Shyong Yu; Yi-Ru Chen; Diana Ickowicz; Ira-Yudovin Farber; Abraham J Domb
Journal:  Int J Nanomedicine       Date:  2012-06-29

8.  Area-specific cell stimulation via surface-mediated gene transfer using apatite-based composite layers.

Authors:  Yushin Yazaki; Ayako Oyane; Yu Sogo; Atsuo Ito; Atsushi Yamazaki; Hideo Tsurushima
Journal:  Int J Mol Sci       Date:  2015-04-14       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.